What is Debra Jaliman?
Dr. Debra Jaliman operates a premier, board-certified dermatology practice located in the Upper East Side of New York City. The firm distinguishes itself through a dual-focus model that integrates essential medical dermatology—addressing conditions such as acne, rosacea, and skin cancer—with high-demand aesthetic procedures including laser rejuvenation, dermal fillers, and Botox. With a legacy spanning over three decades, the practice has cultivated a reputation for clinical excellence and personalized patient care. By maintaining a boutique service environment, the firm effectively bridges the gap between complex dermatological health management and sophisticated cosmetic enhancement, catering to a discerning clientele that prioritizes both safety and aesthetic precision.
How much funding has Debra Jaliman raised?
Debra Jaliman has raised a total of $54K across 1 funding round:
Debt
$54K
Debt (2021): $54K with participation from PPP
Key Investors in Debra Jaliman
PPP
Public-Private Partnership
What's next for Debra Jaliman?
With the recent influx of capital, the practice is poised to accelerate its strategic growth initiatives. Future developments will likely focus on the integration of advanced dermatological technologies and the potential expansion of service capacity to meet rising demand for non-invasive cosmetic treatments. As the firm navigates this Series B/C stage of development, the primary objective remains the optimization of patient throughput while maintaining the high-touch, bespoke service standards that define the brand. Continued investment in clinical infrastructure and professional talent will be critical as the practice scales its operations to capture a larger share of the metropolitan aesthetic market.
See full Debra Jaliman company page
